{
    "Title": "Predicted Impact of Mass Drug Administration on the Development of Protective Immunity against Schistosoma haematobium",
    "URL": "https://doi.org/10.1371/journal.pntd.0003059",
    "Published": "July 31, 2014",
    "Subject_Areas": [
        "Eggs",
        "Antibodies",
        "Antibody therapy",
        "Immunity",
        "Schistosoma haematobium",
        "Immune response",
        "Antibody response",
        "Schistosoma"
    ],
    "Authors": {
        "Kate M. Mitchell": [
            "Centre for Immunity, Infection and Evolution, Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom"
        ],
        "Francisca Mutapi": [
            "Centre for Immunity, Infection and Evolution, Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom"
        ],
        "Takafira Mduluza": [
            "Department of Biochemistry, University of Zimbabwe, Harare, Zimbabwe",
            "College of Health Sciences, University of KwaZulu Natal, Durban, South Africa"
        ],
        "Nicholas Midzi": [
            "National Institute of Health Research, Harare, Zimbabwe"
        ],
        "Nicholas J. Savill": [
            "Centre for Immunity, Infection and Evolution, Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom"
        ],
        "Mark E. J. Woolhouse": [
            "Centre for Immunity, Infection and Evolution, Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom"
        ]
    }
}